A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies.

In conclusion, romiplostim was safe and effective for CIT in most solid tumor patients.
PMID: 32499239 [PubMed - as supplied by publisher]

Source: Haematologica - June 3, 2020 Category: Hematology Authors: Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ Tags: Haematologica Source Type: research